| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $303.9M | -10.3% |
| Cost of Revenue | $149.2M | -9.3% |
| Gross Profit | $154.7M | -11.2% |
| R&D Expense | $31.5M | +5.5% |
| SG&A Expense | $41.2M | +2.9% |
| Operating Income | -$192.4M | -276.0% |
| Interest Expense | -$1.6M | -159.7% |
| Pre-tax Income | -$191.6M | -252.0% |
| Income Tax | -$7.3M |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.1M | +70.5% |
| Accounts Receivable | $43.6M | -17.4% |
| Inventory | $60.6M | +9.6% |
| Current Assets | $193.3M | +18.2% |
| Total Assets | $317.7M | -40.4% |
| Current Liabilities | $91.2M | +8.7% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | — |
| Capital Expenditures | $2.5M | -33.9% |
| Investing Cash Flow | $123.7M | +1369.4% |
| Financing Cash Flow | -$64.2M | -352.7% |
| Free Cash Flow | -$30.7M | -721.5% |
| -265.4% |
| Net Income | -$184.3M | -251.5% |
| EPS (Basic) | -$4.59 | -245.1% |
| EPS (Diluted) | -$4.59 | -245.1% |
| Total Liabilities |
| $112.1M |
| -27.4% |
| Stockholders' Equity | $205.6M | -45.7% |